Canada· CA-DIN-02542420
AMVUTTRA
A vutrisiran product containing vutrisiran (vutrisiran sodium), registered in Canada by ALNYLAM NETHERLANDS B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Vutrisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX18 (vutrisiran), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Vutrisiran · ATC N07XX18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vutrisiran costs, country by country.
Normalised to the WHO defined daily dose (0.278 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vutrisiran · price per daily dose (0.278 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1135.51
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- VUTRISIRAN (VUTRISIRAN SODIUM)
- Manufacturer
- ALNYLAM NETHERLANDS B.V.
- Country
- Canada (CA)
- ATC code
- N07XX18
- ATC class
- Vutrisiran
- Defined daily dose
- 0.278 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vutrisiran in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAMVUTTRA 25 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAlnylam Netherlands B.V.
- FranceAMVUTTRA 25 mg, solution injectable en seringue préremplieALNYLAM NETHERLANDS (PAYS-BAS)
- United KingdomAmvuttra 25mg/0.5ml solution for injection pre-filled syringesAlnylam UK Ltd
- IcelandAmvuttraAlnylam Netherlands B.V.
- NetherlandsAmvuttra 25mg, oplossing voor injectie in voorgevulde spuitAlnylam Netherlands B.V.
- PolandAmvuttraAlnylam Netherlands B.V.
- SwitzerlandAmvuttra
- SwedenAmvuttra 25 mg Injektionsvätska, lösning i förfylld sprutaAlnylam Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amvuttra
- Liechtenstein · Amvuttra
- Norway · Amvuttra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b5bf930-ca22-4692-b294-5792afbac9c6 GET /v1/drugs/8b5bf930-ca22-4692-b294-5792afbac9c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02542420",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N07XX18",
"schedule": [
"Prescription"
],
"drug_code": "103100",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"VUTRISIRAN (VUTRISIRAN SODIUM)"
],
"product_categorization": null
}See everything about vutrisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.